Consistent with the elevated EM cell levels in tumor, naïve (CD45RO−) CD4+ (p = 0.0003) and CD8+ (p = 0.0007) T cells were significantly less prevalent in tumor than in the blood. The gene discussed is CD4; the disease is neoplasm.